New combo treatment targets Crow's feet and hollow eyes
NCT ID NCT07398755
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study observed 29 adults receiving a combination of botulinum toxin (Letybo), hyaluronic acid filler (Saypha Volume Plus), and polynucleotide injections (Philart Eye) around the eyes. The goal was to see how well this holistic approach reduces wrinkles and restores volume over 22 weeks. Researchers measured skin changes and patient satisfaction at several follow-up visits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
botulinum toxin A, hyaluronic acid filler, and polynucleotide
What this could lead to
If successful, this could confirm that a combination of these injectable treatments safely improves wrinkles and volume loss around the eyes for several months.
What could go wrong
This is a small, completed observational study with only 29 participants. Results may not apply to everyone, and the effects are temporary, requiring repeat treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLABELLAR LINES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
YUVELL
Vienna, State of Vienna, 1010, Austria